(Q38721777)

5 September 2017

1 reference

title

Phosphodiesterase inhibitors: alterations in systemic and coronary hemodynamics (English)

1 reference

5 September 2017

K Chatterjee

1

1 reference

5 September 2017

publication date

1 January 1989

1 reference

Basic Research in Cardiology

5 September 2017

published in

1 reference

5 September 2017

volume

84 Suppl 1

1 reference

5 September 2017

page(s)

213-224

1 reference

Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio.

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02650361

Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02650361

Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02650361

Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02650361

Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.

21 January 2018

1 reference

12 December 2020

Diastolic function in patients with severe heart failure: comparison of the effects of enoximone and nitroprusside

1 reference

12 December 2020

Dose-response relation between therapeutic levels of serum digoxin and systolic time intervals

1 reference

12 December 2020

Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure

1 reference

12 December 2020

New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.

1 reference

12 December 2020

Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients

1 reference

12 December 2020

Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure

1 reference

12 December 2020

New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.

1 reference

12 December 2020

Intravenous use of amrinone for the treatment of the failing heart

1 reference

12 December 2020

Physiologic response to the inotropic and vasodilator properties of enoximone

1 reference

12 December 2020

Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure

1 reference

12 December 2020

Characterization of the Cardiovascular Activities of a New Cardiotonic Agent, MDL 17043 (1,3-Dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one)

1 reference

12 December 2020

The role of vasodilator therapy in heart failure

1 reference

12 December 2020

Characterization of the Cardiotonic Effects of Milrinone, a New and Potent Cardiac Bipyridine, on Isolated Tissues from Several Animal Species

1 reference

12 December 2020

Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone

1 reference

12 December 2020

RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure

1 reference

12 December 2020

Hemodynamic assessment of amrinone. A new inotropic agent

1 reference

12 December 2020

Epinephrine infusion in man. Standardization, normal response, and abnormal response in idiopathic hypertrophic subaortic stenosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02650361

1 reference

Dimensions Publication ID

5 September 2017

1052517722

0 references

1 reference